Search research articles
Contact Us
Filters
Showing results (41-50 of 1,457) with videos related to
Page
of 146
Sort By:
Translational Andrology and Urology
|
July 18, 2020
Highlighting the road towards new disease-specific comorbidity indices
Paolo Dell'Oglio, Elio Mazzone, Zhe Tian, et al.
Nature Reviews. Urology
|
June 11, 2010
Pazopanib trial data cannot support first-line use
Claudio Jeldres, Maxine Sun, Paul Perrotte, et al.
European Urology
|
January 6, 2010
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81
Shahrokh F Shariat, Jose A Karam, Pierre I Karakiewicz
European Urology
|
April 10, 2012
Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimens
Maxine Sun, Marco Bianchi, Jens Hansen, et al.
European Urology
|
June 10, 2008
Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone
Felix K-H Chun, Pierre I Karakiewicz, Alberto Briganti
Nature Reviews. Urology
|
May 12, 2010
Treatment of metastatic renal cell carcinoma
Maxine Sun, Giovanni Lughezzani, Paul Perrotte, et al.
European Urology
|
April 22, 2014
Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026
Giorgio Gandaglia, Maxine Sun, Alberto Briganti, et al.
Current Opinion in Supportive and Palliative Care
|
August 10, 2020
Second-line tyrosine kinase inhibitor-therapy after immunotherapy-failure
Marina Deuker, Felix K H Chun, Pierre I Karakiewicz
Future Oncology (London, England)
|
September 12, 2015
Robot-assisted radical prostatectomy in prostate cancer
Giorgio Gandaglia, Francesco Montorsi, Pierre I Karakiewicz, et al.
Rare Tumors
|
April 26, 2012
Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment
Daniel Taussky, Pierre I Karakiewicz, Mathieu Latour, et al.
Page
of 146
Search research articles
Search
Showing results (41-50 of 1,457) with videos related to
Sort By:
Page
of 146
Translational Andrology and Urology
|
July 18, 2020
Highlighting the road towards new disease-specific comorbidity indices
Paolo Dell'Oglio, Elio Mazzone, Zhe Tian, et al.
Nature Reviews. Urology
|
June 11, 2010
Pazopanib trial data cannot support first-line use
Claudio Jeldres, Maxine Sun, Paul Perrotte, et al.
European Urology
|
January 6, 2010
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81
Shahrokh F Shariat, Jose A Karam, Pierre I Karakiewicz
European Urology
|
April 10, 2012
Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimens
Maxine Sun, Marco Bianchi, Jens Hansen, et al.
European Urology
|
June 10, 2008
Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone
Felix K-H Chun, Pierre I Karakiewicz, Alberto Briganti
Nature Reviews. Urology
|
May 12, 2010
Treatment of metastatic renal cell carcinoma
Maxine Sun, Giovanni Lughezzani, Paul Perrotte, et al.
European Urology
|
April 22, 2014
Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026
Giorgio Gandaglia, Maxine Sun, Alberto Briganti, et al.
Current Opinion in Supportive and Palliative Care
|
August 10, 2020
Second-line tyrosine kinase inhibitor-therapy after immunotherapy-failure
Marina Deuker, Felix K H Chun, Pierre I Karakiewicz
Future Oncology (London, England)
|
September 12, 2015
Robot-assisted radical prostatectomy in prostate cancer
Giorgio Gandaglia, Francesco Montorsi, Pierre I Karakiewicz, et al.
Rare Tumors
|
April 26, 2012
Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment
Daniel Taussky, Pierre I Karakiewicz, Mathieu Latour, et al.
Page
of 146